FDA Takes Enforcement Action Against Companies Marketing Unapproved Narcotic Drugs

In a post by Mr. Kurt R. Karst at FDA LAW BLOG, reported that, FDA announced that the Agency has taken enforcement action against several manufacturers of unapproved prescription narcotics. The 9 Warning Letters issued by FDA concern 14 narcotic drug products, including morphine sulfate, hydromorphone, and oxycodone. The Warning Letters direct the companies to stop manufacturing and distributing the specific narcotic drug products in certain dosage forms that lack FDA approval.

The details can be read here.